Since 1997, Molecular Diagnostics Laboratories (MDL) has been a pioneer in personalized medicine and pharmacogenetics.
MDL was the brainchild of a professor at University of Cincinnati, who, early on, understood the benefits of personalizing medical treatment based on genetic make up of patients.
MDL offers latest genetic tests on cutting edge instruments. MDL has strong ties to medical community and stays abreast of latest discoveries. Since inception, MDL has been at the forefront of theranostics and continues to expand its capabilities and testing expertise.
MDL offers scientifically valid and clinically relevant tests under strict guidelines of CLIA* and CAP**.
*CLIA – Clinical Laboratory Improvement Amendments of 1988.
** CAP – College of American Pathologists.
Expertise and Support Accessible by MDL
Molecular Diagnostics Laboratories is a wholly owned subsidiary of SIDIS Global Corp. Other SIDIS companies include Propel Labs, a biotechnology instrumentation company, Surgical Energetics LLC, developing innovative suture technology, MobileMedTek, a medical device company and bioLOGIC, a life science incubator.